Bukwang Pharmaceutical Co., Ltd. (KRX:003000)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,680.00
-620.00 (-8.49%)
Apr 28, 2026, 3:30 PM KST
67.42%
Market Cap 659.08B
Revenue (ttm) 200.71B
Net Income (ttm) 12.56B
Shares Out 98.66M
EPS (ttm) 152.00
PE Ratio 43.95
Forward PE n/a
Dividend 150.00 (2.05%)
Ex-Dividend Date Dec 29, 2025
Volume 4,011,055
Average Volume 2,113,961
Open 7,200.00
Previous Close 7,300.00
Day's Range 6,360.00 - 7,220.00
52-Week Range 3,200.00 - 9,890.00
Beta 0.37
RSI 42.77
Earnings Date Apr 21, 2026

About Bukwang Pharmaceutical

Bukwang Pharmaceutical Co., Ltd. develops, produces, and sells pharmaceutical products in South Korea and internationally. It offers its products in oral solid dosage forms, injections, oral solutions, external solutions, and ointments. The company also provides ethical drugs, including drugs for treating diabetic peripheral neuropathy, hypothyroidism, toxic liver disease, chronic hepatitis, liver cirrhosis, and iron-deficiency anemia; over-the-counter drugs, such as fever and pain relief medication, gastrointestinal medication, cold medication... [Read more]

Sector Healthcare
Founded 1960
Employees 615
Stock Exchange Korea Stock Exchange
Ticker Symbol 003000
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.